Log In
Print this Print this

tacrolimus (SPI-026)

  Manage Alerts
Collapse Summary General Information
Company Selten Pharma Inc.
DescriptionBone morphogenetic protein receptor type II (BMPRII) pathway activator
Molecular Target Bone morphogenetic protein receptor type II (BMPRII)
Mechanism of ActionBone morphogenic protein (BMP) type II receptor agonist
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase II
Standard IndicationHypertension
Indication DetailsTreat pulmonary arterial hypertension
Regulatory Designation U.S. - Orphan Drug (Treat pulmonary arterial hypertension)
PartnerVivus Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today